FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics, and can be used to reduce blood loss in operative delivery in obstetric patients of high risk groups. For this purpose, intraoperatively immediately after the umbilical cord is crossed before the placenta is separated, Terlipressin preparation 0.4 mg is added with addition of 0.9 % sodium chloride solution and bringing the administered volume to 10 ml into the muscular tissue of the uterus through a uterine incision in equal doses of 0.2 mg into uterus incision angles.
EFFECT: method enables reducing blood loss in the obstetric patients of the high obstetric risk group in a combination with normalizing such cardiovascular parameters as cardiac output, systemic vascular resistance, cardiac index, arterial pressure in the absence of complications specific for the intravenous introduction.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF MASSIVE BLEEDING DURING CENTRAL PLACENTA PREVIA IN PATIENTS WITH PLACENTA ACCRETA | 2023 |
|
RU2806515C1 |
METHOD FOR REDUCING INTRAOPERATIVE BLOOD LOSS IN MYOMECTOMY DURING CESAREAN SECTION | 2024 |
|
RU2821822C1 |
METHOD FOR PREVENTION OF EARLY POSTPARTUM BLEEDING IN PATIENTS WITH HYPERTENSIVE DISORDERS DURING CESAREAN SECTION | 2022 |
|
RU2786814C1 |
A METHOD OF PREVENTING AND STOPPING POSTPARTUM UTERINE BLEEDING | 2020 |
|
RU2744751C1 |
METHOD FOR COAGULOPATIC BLEEDING PREVENTION DURING CESAREAN SECTION | 2016 |
|
RU2629040C1 |
METHOD OF PREVENTION OF POSTPARTUM HEMORRHAGE DURING CAESAREAN SECTION IN HIGH-RISK PATIENTS (PLACENTA PREVIA, FAILURE OF THE UTERINE SCAR) | 2023 |
|
RU2797734C1 |
METHOD FOR RELIEVING BLOOD LOSS IN CAESAREAN SECTION | 2015 |
|
RU2638459C2 |
METHOD OF TREATING AND PREVENTING OBSTETRICAL HAEMORRHAGES | 2014 |
|
RU2565841C1 |
METHOD FOR CORRECTION OF BLOOD LOSS IN OPERATIVE RESOLUTION OF PREGNANT WOMEN WITH INGROWN PLACENTA | 2019 |
|
RU2704464C1 |
METHOD FOR TEMPORARY OCCLUSION OF COMMON ILIAC ARTERIES DURING ORGAN-PRESERVING OPERATIVE DELIVERY IN PATIENTS WITH PLACENTAR INGROWTH | 2016 |
|
RU2625286C1 |
Authors
Dates
2019-12-23—Published
2018-07-31—Filed